Robert C Young - Net Worth and Insider Trading
Robert C Young Net Worth
The estimated net worth of Robert C Young is at least $12 Million dollars as of 2024-11-08. Robert C Young is the Director of West Pharmaceutical Services Inc and owns about 37,182 shares of West Pharmaceutical Services Inc (WST) stock worth over $12 Million. Robert C Young is also the Director of AVEO Pharmaceuticals Inc and owns about 1,000 shares of AVEO Pharmaceuticals Inc (AVEO) stock worth over $15,000. Details can be seen in Robert C Young's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Robert C Young has not made any transactions after 2013-02-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Robert C Young
Robert C Young Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Robert C Young owns 2 companies in total, including AVEO Pharmaceuticals Inc (AVEO) , and West Pharmaceutical Services Inc (WST) .
Click here to see the complete history of Robert C Young’s form 4 insider trades.
Insider Ownership Summary of Robert C Young
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
AVEO | AVEO Pharmaceuticals Inc | 2016-05-26 | director |
WST | West Pharmaceutical Services Inc | 2011-08-30 | director |
Robert C Young Latest Holdings Summary
Robert C Young currently owns a total of 2 stocks. Among these stocks, Robert C Young owns 37,182 shares of West Pharmaceutical Services Inc (WST) as of August 30, 2011, with a value of $12 Million and a weighting of 99.88%. Robert C Young also owns 1,000 shares of AVEO Pharmaceuticals Inc (AVEO) as of February 19, 2013, with a value of $15,000 and a weighting of 0.12%.
Latest Holdings of Robert C Young
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
WST | West Pharmaceutical Services Inc | 2011-08-30 | 37,182 | 323.42 | 12,025,402 |
AVEO | AVEO Pharmaceuticals Inc | 2013-02-19 | 1,000 | 15.00 | 15,000 |
Holding Weightings of Robert C Young
Robert C Young Form 4 Trading Tracker
According to the SEC Form 4 filings, Robert C Young has made a total of 0 transactions in West Pharmaceutical Services Inc (WST) over the past 5 years. The most-recent trade in West Pharmaceutical Services Inc is the sale of 4,708 shares on August 30, 2011, which brought Robert C Young around $94,231.
According to the SEC Form 4 filings, Robert C Young has made a total of 0 transactions in AVEO Pharmaceuticals Inc (AVEO) over the past 5 years. The most-recent trade in AVEO Pharmaceuticals Inc is the acquisition of 99 shares on February 19, 2013, which cost Robert C Young around $6,534.
Insider Trading History of Robert C Young
- 1
Robert C Young Trading Performance
GuruFocus tracks the stock performance after each of Robert C Young's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Robert C Young is -15.1%. GuruFocus also compares Robert C Young's trading performance to market benchmark return within the same time period. The performance of stocks bought by Robert C Young within 3 months outperforms 1 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Robert C Young's insider trading performs compared to the benchmark.
Performance of Robert C Young
Robert C Young Ownership Network
Ownership Network List of Robert C Young
Ownership Network Relation of Robert C Young
Robert C Young Owned Company Details
What does AVEO Pharmaceuticals Inc do?
Who are the key executives at AVEO Pharmaceuticals Inc?
Robert C Young is the director of AVEO Pharmaceuticals Inc. Other key executives at AVEO Pharmaceuticals Inc include Chief Operating Officer Jebediah Ledell , director & President & CEO Michael P Bailey , and Chief Commercial Officer Michael Ferraresso .
AVEO Pharmaceuticals Inc (AVEO) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of AVEO Pharmaceuticals Inc (AVEO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of AVEO Pharmaceuticals Inc (AVEO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
AVEO Pharmaceuticals Inc (AVEO)'s detailed insider trading history can be found in Insider Trading Tracker table.
AVEO Pharmaceuticals Inc Insider Transactions
Robert C Young Mailing Address
Above is the net worth, insider trading, and ownership report for Robert C Young. Currently GuruFocus does not have mailing address information for Robert C Young.